{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:27:02Z","timestamp":1791977222570,"version":"4.4.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T00:00:00Z","timestamp":1702080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T00:00:00Z","timestamp":1702080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Major Projects Jointly Constructed by Henan Province and Ministry of Science and Technology","award":["SBGJ202101003"],"award-info":[{"award-number":["SBGJ202101003"]}]},{"name":"Young talents of Health Science and Technology Innovation in Henan Province","award":["YXKC2021002"],"award-info":[{"award-number":["YXKC2021002"]}]},{"name":"Young talents of Health Science and Technology Innovation in Henan Province","award":["YQRC2023010"],"award-info":[{"award-number":["YQRC2023010"]}]},{"name":"Open Research Fund of National Health Commission Key Laboratory of Birth Defects Prevention & Henan Key Laboratory of Population Defects Prevention","award":["ZD202304"],"award-info":[{"award-number":["ZD202304"]}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["232300421121"],"award-info":[{"award-number":["232300421121"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["232300421281"],"award-info":[{"award-number":["232300421281"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32300627"],"award-info":[{"award-number":["32300627"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Growing evidence has suggested that Type I Interferon (I-IFN) plays a potential role in the pathogenesis of Down Syndrome (DS). This work investigates the underlying function of MX1, an effector gene of I-IFN, in DS-associated transcriptional regulation and phenotypic modulation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed assay for transposase-accessible chromatin with high-throughout sequencing (ATAC-seq) to explore the difference of chromatin accessibility between DS derived amniocytes (DSACs) and controls. We then combined the annotated differentially expressed genes (DEGs) and enriched transcriptional factors (TFs) targeting the promoter region from ATAC-seq results with the DEGs in RNA-seq, to identify key genes and pathways involved in alterations of biological processes and pathways in DS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Binding motif analysis showed a significant increase in chromatin accessibility of genes related to neural cell function, among others, in DSACs, which is primarily regulated by members of the activator protein-1 (AP-1) transcriptional factor family. Further studies indicated that MX Dynamin Like GTPase 1 (MX1), defined as one of the key effector genes of I-IFN, is a critical upstream regulator. Its overexpression induced expression of AP-1 TFs and mediated inflammatory response, thus leading to decreased cellular viability of DS cells. Moreover, treatment with specific AP-1 inhibitor T-5224 improved DS-associated phenotypes in DSACs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study demonstrates that MX1-mediated AP-1 activation is partially responsible for cellular dysfunction of DS. T-5224 effectively ameliorated DS-associated phenotypes in DSACs, suggesting it as a potential treatment option for DS patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40659-023-00474-x","type":"journal-article","created":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T03:01:57Z","timestamp":1702090917000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Integration of ATAC-seq and RNA-seq identifies MX1-mediated AP-1 transcriptional regulation as a therapeutic target for Down syndrome"],"prefix":"10.1186","volume":"56","author":[{"given":"Zhenglong","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranran","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenke","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingtao","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4904-6128","authenticated-orcid":false,"given":"Shixiu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,9]]},"reference":[{"issue":"4","key":"474_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/gim.2016.127","volume":"19","author":"G de Graaf","year":"2017","unstructured":"de Graaf G, Buckley F, Skotko BG. Estimation of the number of people with Down syndrome in the United States. Genet Med. 2017;19(4):439\u201347.","journal-title":"Genet Med"},{"issue":"24","key":"474_CR2","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1056\/NEJMra1706537","volume":"382","author":"MJ Bull","year":"2020","unstructured":"Bull MJ. Down syndrome. N Engl J Med. 2020;382(24):2344\u201352.","journal-title":"N Engl J Med"},{"issue":"10","key":"474_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2004-5-10-244","volume":"5","author":"K Gardiner","year":"2004","unstructured":"Gardiner K. Gene-dosage effects in Down syndrome and trisomic mouse models. Genome Biol. 2004;5(10): 244.","journal-title":"Genome Biol"},{"issue":"2","key":"474_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.pneurobio.2007.02.006","volume":"82","author":"RX Moldrich","year":"2007","unstructured":"Moldrich RX, Dauphinot L, Laffaire J, Rossier J, Potier MC. Down syndrome gene dosage imbalance on cerebellum development. Prog Neurobiol. 2007;82(2):87\u201394.","journal-title":"Prog Neurobiol"},{"issue":"1","key":"474_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1474-4422(22)00408-2","volume":"22","author":"AH Boerwinkle","year":"2023","unstructured":"Boerwinkle AH, Gordon BA, Wisch J, Flores S, Henson RL, Butt OH, McKay N, Chen CD, Benzinger TLS, Fagan AM, et al. Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer\u2019s disease: a cross-sectional study. Lancet Neurol. 2023;22(1):55\u201365.","journal-title":"Lancet Neurol"},{"issue":"5","key":"474_CR6","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1002\/alz.12835","volume":"19","author":"XQ Chen","year":"2023","unstructured":"Chen XQ, Zuo X, Becker A, Head E, Mobley WC. Reduced synaptic proteins and SNARE complexes in down syndrome with Alzheimer\u2019s disease and the Dp16 mouse down syndrome model: impact of APP gene dose. Alzheimers Dement. 2023;19(5):2095\u2013116.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"474_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41582-018-0132-6","volume":"15","author":"IT Lott","year":"2019","unstructured":"Lott IT, Head E. Dementia in Down syndrome: unique insights for Alzheimer disease research. Nat Rev Neurol. 2019;15(3):135\u201347.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"474_CR8","doi-asserted-by":"publisher","first-page":"572","DOI":"10.7326\/M20-4986","volume":"174","author":"AK Clift","year":"2021","unstructured":"Clift AK, Coupland CAC, Keogh RH, Hemingway H, Hippisley-Cox J. COVID-19 mortality risk in Down syndrome: results from a cohort study of 8 million adults. Ann Intern Med. 2021;174(4):572\u20136.","journal-title":"Ann Intern Med"},{"issue":"1","key":"474_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2249.2011.04335.x","volume":"164","author":"G Ram","year":"2011","unstructured":"Ram G, Chinen J. Infections and immunodeficiency in Down syndrome. Clin Exp Immunol. 2011;164(1):9\u201316.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"474_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1525-1470.2007.00412.x","volume":"24","author":"M Daneshpazhooh","year":"2007","unstructured":"Daneshpazhooh M, Nazemi TM, Bigdeloo L, Yoosefi M. Mucocutaneous findings in 100 children with Down syndrome. Pediatr Dermatol. 2007;24(3):317\u201320.","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"474_CR11","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00125-006-0231-6","volume":"49","author":"R Bergholdt","year":"2006","unstructured":"Bergholdt R, Eising S, Nerup J, Pociot F. Increased prevalence of Down\u2019s syndrome in individuals with type 1 diabetes in Denmark: a nationwide population-based study. Diabetologia. 2006;49(6):1179\u201382.","journal-title":"Diabetologia"},{"issue":"12","key":"474_CR12","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1038\/s41375-021-01414-y","volume":"35","author":"AC Boucher","year":"2021","unstructured":"Boucher AC, Caldwell KJ, Crispino JD, Flerlage JE. Clinical and biological aspects of myeloid leukemia in Down syndrome. Leukemia. 2021;35(12):3352\u201360.","journal-title":"Leukemia"},{"key":"474_CR13","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.2147\/JIR.S280953","volume":"14","author":"H Chung","year":"2021","unstructured":"Chung H, Green PHR, Wang TC, Kong XF. Interferon-driven immune dysregulation in Down syndrome: a review of the evidence. J Inflamm Res. 2021;14:5187\u2013200.","journal-title":"J Inflamm Res"},{"issue":"6","key":"474_CR14","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10875-020-00803-9","volume":"40","author":"XF Kong","year":"2020","unstructured":"Kong XF, Worley L, Rinchai D, Bondet V, Jithesh PV, Goulet M, Nonnotte E, Rebillat AS, Conte M, Mircher C, et al. Three copies of four interferon receptor genes underlie a mild type I interferonopathy in Down syndrome. J Clin Immunol. 2020;40(6):807\u201319.","journal-title":"J Clin Immunol"},{"key":"474_CR15","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.coi.2021.06.006","volume":"72","author":"L Malle","year":"2021","unstructured":"Malle L, Bogunovic D. Down syndrome and type I interferon: not so simple. Curr Opin Immunol. 2021;72:196\u2013205.","journal-title":"Curr Opin Immunol"},{"issue":"11","key":"474_CR16","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1016\/j.immuni.2022.09.007","volume":"55","author":"L Malle","year":"2022","unstructured":"Malle L, Martin-Fernandez M, Buta S, Richardson A, Bush D, Bogunovic D. Excessive negative regulation of type I interferon disrupts viral control in individuals with Down syndrome. Immunity. 2022;55(11):2074\u201384.e2075.","journal-title":"Immunity"},{"issue":"7","key":"474_CR17","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.stem.2022.06.007","volume":"29","author":"M Jin","year":"2022","unstructured":"Jin M, Xu R, Wang L, Alam MM, Ma Z, Zhu S, Martini AC, Jadali A, Bernabucci M, Xie P, et al. Type-I-interferon signaling drives microglial dysfunction and senescence in human iPSC models of Down syndrome and Alzheimer\u2019s disease. Cell Stem Cell. 2022;29(7):1135\u201353.e1138.","journal-title":"Cell Stem Cell"},{"issue":"7","key":"474_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107012","volume":"26","author":"C Chi","year":"2023","unstructured":"Chi C, Knight WE, Riching AS, Zhang Z, Tatavosian R, Zhuang Y, Moldovan R, Rachubinski AL, Gao D, Xu H, et al. Interferon hyperactivity impairs cardiogenesis in Down syndrome via downregulation of canonical wnt signaling. iScience. 2023;26(7): 107012.","journal-title":"iScience"},{"issue":"5\u20136","key":"474_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.cytogfr.2007.06.001","volume":"18","author":"O Haller","year":"2007","unstructured":"Haller O, Kochs G, Weber F. Interferon, Mx, and viral countermeasures. Cytokine Growth Factor Rev. 2007;18(5\u20136):425\u201333.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"474_CR20","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1128\/CMR.14.4.778-809.2001","volume":"14","author":"CE Samuel","year":"2001","unstructured":"Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev. 2001;14(4):778\u2013809 (table of contents).","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"474_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40246-021-00325-4","volume":"15","author":"F Antonaros","year":"2021","unstructured":"Antonaros F, Zenatelli R, Guerri G, Bertelli M, Locatelli C, Vione B, Catapano F, Gori A, Vitale L, Pelleri MC, et al. The transcriptome profile of human trisomy 21 blood cells. Hum Genom. 2021;15(1):25.","journal-title":"Hum Genom"},{"issue":"7","key":"474_CR22","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/nbt1412","volume":"26","author":"Y Aikawa","year":"2008","unstructured":"Aikawa Y, Morimoto K, Yamamoto T, Chaki H, Hashiramoto A, Narita H, Hirono S, Shiozawa S. Treatment of arthritis with a selective inhibitor of c-Fos\/activator protein-1. Nat Biotechnol. 2008;26(7):817\u201323.","journal-title":"Nat Biotechnol"},{"issue":"12","key":"474_CR23","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1007\/s10529-012-1022-4","volume":"34","author":"S Izuta","year":"2012","unstructured":"Izuta S, Ueki M, Ueno M, Nishina K, Shiozawa S, Maekawa N. T-5224, a selective inhibitor of c-Fos\/activator protein-1, attenuates lipopolysaccharide-induced liver injury in mice. Biotechnol Lett. 2012;34(12):2175\u201382.","journal-title":"Biotechnol Lett"},{"issue":"5","key":"474_CR24","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1124\/dmd.110.037952","volume":"39","author":"S Uchihashi","year":"2011","unstructured":"Uchihashi S, Fukumoto H, Onoda M, Hayakawa H, Ikushiro S, Sakaki T. Metabolism of the c-Fos\/activator protein-1 inhibitor T-5224 by multiple human UDP-glucuronosyltransferase isoforms. Drug Metab Dispos. 2011;39(5):803\u201313.","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"474_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12967-021-02932-0","volume":"19","author":"HN Wang","year":"2021","unstructured":"Wang HN, Ji K, Zhang LN, Xie CC, Li WY, Zhao ZF, Chen JJ. Inhibition of c-Fos expression attenuates IgE-mediated mast cell activation and allergic inflammation by counteracting an inhibitory AP1\/Egr1\/IL-4 axis. J Transl Med. 2021;19(1):261.","journal-title":"J Transl Med"},{"issue":"16","key":"474_CR26","doi-asserted-by":"publisher","first-page":"6930","DOI":"10.1021\/jm5004733","volume":"57","author":"N Ye","year":"2014","unstructured":"Ye N, Ding Y, Wild C, Shen Q, Zhou J. Small molecule inhibitors targeting activator protein 1 (AP-1). J Med Chem. 2014;57(16):6930\u201348.","journal-title":"J Med Chem"},{"issue":"1","key":"474_CR27","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1038\/s41467-022-33333-6","volume":"13","author":"D Feng","year":"2022","unstructured":"Feng D, Chen Y, Dai R, Bian S, Xue W, Zhu Y, Li Z, Yang Y, Zhang Y, Zhang J, et al. Chromatin organizer SATB1 controls the cell identity of CD4(+) CD8(+) double-positive thymocytes by regulating the activity of super-enhancers. Nat Commun. 2022;13(1):5554.","journal-title":"Nat Commun"},{"issue":"1","key":"474_CR28","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/s42003-021-02501-7","volume":"4","author":"Y Yang","year":"2021","unstructured":"Yang Y, Ye X, Dai R, Li Z, Zhang Y, Xue W, Zhu Y, Feng D, Qin L, Wang X, et al. Phase separation of Epstein-Barr virus EBNA2 protein reorganizes chromatin topology for epigenetic regulation. Commun Biol. 2021;4(1):967.","journal-title":"Commun Biol"},{"issue":"Database issue","key":"474_CR29","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43(Database issue):D447\u201352.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"474_CR30","doi-asserted-by":"publisher","first-page":"W212","DOI":"10.1093\/nar\/gkz446","volume":"47","author":"AB Keenan","year":"2019","unstructured":"Keenan AB, Torre D, Lachmann A, Leong AK, Wojciechowicz ML, Utti V, Jagodnik KM, Kropiwnicki E, Wang Z. Ma\u2019ayan A: ChEA3: transcription factor enrichment analysis by orthogonal omics integration. Nucleic Acids Res. 2019;47(W1):W212\u201324.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"474_CR31","doi-asserted-by":"publisher","first-page":"D729","DOI":"10.1093\/nar\/gky1094","volume":"47","author":"R Zheng","year":"2019","unstructured":"Zheng R, Wan C, Mei S, Qin Q, Wu Q, Sun H, Chen CH, Brown M, Zhang X, Meyer CA, et al. Cistrome Data Browser: expanded datasets and new tools for gene regulatory analysis. Nucleic Acids Res. 2019;47(D1):D729\u201335.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"474_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.molcel.2013.08.037","volume":"52","author":"J Gertz","year":"2013","unstructured":"Gertz J, Savic D, Varley KE, Partridge EC, Safi A, Jain P, Cooper GM, Reddy TE, Crawford GE, Myers RM. Distinct properties of cell-type-specific and shared transcription factor binding sites. Mol Cell. 2013;52(1):25\u201336.","journal-title":"Mol Cell"},{"issue":"1","key":"474_CR33","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.stem.2021.12.002","volume":"29","author":"HS Meharena","year":"2022","unstructured":"Meharena HS, Marco A, Dileep V, Lockshin ER, Akatsu GY, Mullahoo J, Watson LA, Ko T, Guerin LN, Abdurrob F, et al. Down-syndrome-induced senescence disrupts the nuclear architecture of neural progenitors. Cell Stem Cell. 2022;29(1):116\u201330.e117.","journal-title":"Cell Stem Cell"},{"key":"474_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.621374","volume":"9","author":"W Shi","year":"2021","unstructured":"Shi W, Yang F, Dai R, Sun Y, Chu Y, Liao S, Hao B. METTL3-mediated N6-methyladenosine modification is involved in the dysregulation of NRIP1 expression in Down syndrome. Front Cell Dev Biol. 2021;9: 621374.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"474_CR35","first-page":"54","volume":"33","author":"JL Down","year":"1995","unstructured":"Down JL. Observations on an ethnic classification of idiots. 1866. Ment Retard. 1995;33(1):54\u20136.","journal-title":"Ment Retard"},{"issue":"18","key":"474_CR36","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/bdr2.1589","volume":"111","author":"CT Mai","year":"2019","unstructured":"Mai CT, Isenburg JL, Canfield MA, Meyer RE, Correa A, Alverson CJ, Lupo PJ, Riehle-Colarusso T, Cho SJ, Aggarwal D, et al. National population-based estimates for major birth defects, 2010\u20132014. Birth Defects Res. 2019;111(18):1420\u201335.","journal-title":"Birth Defects Res"},{"issue":"4","key":"474_CR37","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.arr.2005.11.001","volume":"5","author":"DJ Keating","year":"2006","unstructured":"Keating DJ, Chen C, Pritchard MA. Alzheimer\u2019s disease and endocytic dysfunction: clues from the Down syndrome-related proteins, DSCR1 and ITSN1. Ageing Res Rev. 2006;5(4):388\u2013401.","journal-title":"Ageing Res Rev"},{"issue":"4","key":"474_CR38","doi-asserted-by":"publisher","first-page":"dmm049712","DOI":"10.1242\/dmm.049712","volume":"16","author":"AJ Moyer","year":"2023","unstructured":"Moyer AJ, Fernandez FX, Li Y, Klinedinst DK, Florea LD, Kazuki Y, Oshimura M, Reeves RH. Overexpression screen of chromosome 21 genes reveals modulators of sonic hedgehog signaling relevant to Down syndrome. Dis Model Mech. 2023;16(4):dmm049712.","journal-title":"Dis Model Mech"},{"issue":"6","key":"474_CR39","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41388-021-02126-4","volume":"41","author":"EC Page","year":"2022","unstructured":"Page EC, Heatley SL, Eadie LN, McClure BJ, de Bock CE, Omari S, Yeung DT, Hughes TP, Thomas PQ, White DL. HMGN1 plays a significant role in CRLF2 driven down syndrome leukemia and provides a potential therapeutic target in this high-risk cohort. Oncogene. 2022;41(6):797\u2013808.","journal-title":"Oncogene"},{"issue":"6","key":"474_CR40","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/alz.12463","volume":"18","author":"M Sawa","year":"2022","unstructured":"Sawa M, Overk C, Becker A, Derse D, Albay R, Weldy K, Salehi A, Beach TG, Doran E, Head E, et al. Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model. Alzheimers Dement. 2022;18(6):1203\u201334.","journal-title":"Alzheimers Dement"},{"issue":"10","key":"474_CR41","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1016\/j.ymthe.2021.05.023","volume":"29","author":"M Parrini","year":"2021","unstructured":"Parrini M, Naskar S, Alberti M, Colombi I, Morelli G, Rocchi A, Nanni M, Piccardi F, Charles S, Ronzitti G, et al. Restoring neuronal chloride homeostasis with anti-NKCC1 gene therapy rescues cognitive deficits in a mouse model of Down syndrome. Mol Ther. 2021;29(10):3072\u201392.","journal-title":"Mol Ther"},{"issue":"6610","key":"474_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/science.abq4515","volume":"377","author":"M Manfredi-Lozano","year":"2022","unstructured":"Manfredi-Lozano M, Leysen V, Adamo M, Paiva I, Rovera R, Pignat JM, Timzoura FE, Candlish M, Eddarkaoui S, Malone SA, et al. GnRH replacement rescues cognition in Down syndrome. Science. 2022;377(6610): eabq4515.","journal-title":"Science"},{"issue":"17","key":"474_CR43","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1080\/14656566.2018.1529167","volume":"19","author":"ML Palumbo","year":"2018","unstructured":"Palumbo ML, McDougle CJ. Pharmacotherapy of Down syndrome. Expert Opin Pharmacother. 2018;19(17):1875\u201389.","journal-title":"Expert Opin Pharmacother"},{"issue":"12","key":"474_CR44","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nmeth.2688","volume":"10","author":"JD Buenrostro","year":"2013","unstructured":"Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods. 2013;10(12):1213\u20138.","journal-title":"Nat Methods"},{"issue":"1\u20132","key":"474_CR45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2012.01.001","volume":"148","author":"S Katada","year":"2012","unstructured":"Katada S, Imhof A, Sassone-Corsi P. Connecting threads: epigenetics and metabolism. Cell. 2012;148(1\u20132):24\u20138.","journal-title":"Cell"},{"issue":"5","key":"474_CR46","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.molcel.2005.02.010","volume":"17","author":"G Wang","year":"2005","unstructured":"Wang G, Balamotis MA, Stevens JL, Yamaguchi Y, Handa H, Berk AJ. Mediator requirement for both recruitment and postrecruitment steps in transcription initiation. Mol Cell. 2005;17(5):683\u201394.","journal-title":"Mol Cell"},{"issue":"7951","key":"474_CR47","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41586-023-05736-y","volume":"615","author":"L Malle","year":"2023","unstructured":"Malle L, Patel RS, Martin-Fernandez M, Stewart OJ, Philippot Q, Buta S, Richardson A, Barcessat V, Taft J, Bastard P, et al. Autoimmunity in Down\u2019s syndrome via cytokines, CD4 T cells and CD11c(+) B cells. Nature. 2023;615(7951):305\u201314.","journal-title":"Nature"},{"issue":"6","key":"474_CR48","first-page":"639","volume":"106","author":"R Tazi-Ahnini","year":"2000","unstructured":"Tazi-Ahnini R, di Giovine FS, McDonagh AJ, Messenger AG, Amadou C, Cox A, Duff GW, Cork MJ. Structure and polymorphism of the human gene for the interferon-induced p78 protein (MX1): evidence of association with alopecia areata in the Down syndrome region. Hum Genet. 2000;106(6):639\u201345.","journal-title":"Hum Genet"},{"issue":"19","key":"474_CR49","doi-asserted-by":"publisher","first-page":"e0064521","DOI":"10.1128\/JVI.00645-21","volume":"95","author":"H Wang","year":"2021","unstructured":"Wang H, Kong N, Jiao Y, Dong S, Sun D, Chen X, Zheng H, Tong W, Yu H, Yu L, et al. EGR1 suppresses porcine epidemic diarrhea virus replication by regulating IRAV to degrade viral nucleocapsid protein. J Virol. 2021;95(19):e0064521.","journal-title":"J Virol"},{"key":"474_CR50","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.3389\/fmicb.2018.02326","volume":"9","author":"Z Zhu","year":"2018","unstructured":"Zhu Z, Du X, Li P, Zhang X, Yang F, Cao W, Tian H, Zhang K, Liu X, Zheng H. Early growth response gene-1 suppresses foot-and-mouth disease virus replication by enhancing type I interferon pathway signal transduction. Front Microbiol. 2018;9:2326.","journal-title":"Front Microbiol"},{"issue":"2","key":"474_CR51","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0955-0674(97)80068-3","volume":"9","author":"M Karin","year":"1997","unstructured":"Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol. 1997;9(2):240\u20136.","journal-title":"Curr Opin Cell Biol"},{"issue":"4","key":"474_CR52","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.4049\/jimmunol.173.4.2571","volume":"173","author":"YN Lee","year":"2004","unstructured":"Lee YN, Tuckerman J, Nechushtan H, Schutz G, Razin E, Angel P. c-Fos as a regulator of degranulation and cytokine production in FcepsilonRI-activated mast cells. J Immunol. 2004;173(4):2571\u20137.","journal-title":"J Immunol"},{"issue":"6","key":"474_CR53","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1172\/JCI119277","volume":"99","author":"S Shiozawa","year":"1997","unstructured":"Shiozawa S, Shimizu K, Tanaka K, Hino K. Studies on the contribution of c-fos\/AP-1 to arthritic joint destruction. J Clin Invest. 1997;99(6):1210\u20136.","journal-title":"J Clin Invest"},{"issue":"6","key":"474_CR54","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrd1109","volume":"2","author":"JS Smolen","year":"2003","unstructured":"Smolen JS, Steiner G. Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov. 2003;2(6):473\u201388.","journal-title":"Nat Rev Drug Discov"},{"issue":"Suppl 1","key":"474_CR55","doi-asserted-by":"publisher","first-page":"i86","DOI":"10.1136\/ard.2009.119396","volume":"69","author":"EF Wagner","year":"2010","unstructured":"Wagner EF. Bone development and inflammatory disease is regulated by AP-1 (Fos\/Jun). Ann Rheum Dis. 2010;69(Suppl 1):i86\u20138.","journal-title":"Ann Rheum Dis"},{"key":"474_CR56","doi-asserted-by":"publisher","first-page":"baaa055","DOI":"10.1093\/database\/baaa055","volume":"2020","author":"X Guo","year":"2020","unstructured":"Guo X, Chen F, Gao F, Li L, Liu K, You L, Hua C, Yang F, Liu W, Peng C, et al. CNSA: a data repository for archiving omics data. Database (Oxford). 2020;2020:baaa055.","journal-title":"Database (Oxford)"},{"issue":"8","key":"474_CR57","first-page":"799","volume":"42","author":"FZ Chen","year":"2020","unstructured":"Chen FZ, You LJ, Yang F, Wang LN, Guo XQ, Gao F, Hua C, Tan C, Fang L, Shan RQ, et al. CNGBdb: China National GeneBank DataBase. Yi Chuan. 2020;42(8):799\u2013809.","journal-title":"Yi Chuan"}],"container-title":["Biological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-023-00474-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40659-023-00474-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-023-00474-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T04:22:26Z","timestamp":1702095746000},"score":1,"resource":{"primary":{"URL":"https:\/\/biolres.biomedcentral.com\/articles\/10.1186\/s40659-023-00474-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,9]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["474"],"URL":"https:\/\/doi.org\/10.1186\/s40659-023-00474-x","relation":{},"ISSN":["0717-6287"],"issn-type":[{"value":"0717-6287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,9]]},"assertion":[{"value":"6 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Henan Provincial People\u2019s Hospital, China, with No. 2020-75.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participated pregnant women have signed informed consent and agreed to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}